Tissue exam by pathologist
CPT 88305 covers the pathologist's examination of tissue samples removed during biopsies or surgical procedures. This is the most frequently billed pathology code and applies to routine tissue specimens like skin biopsies, polyps, and small lesions.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Bill one unit of 88305 per specimen submitted in a separate container with unique anatomic site identification, not per slide or block
Impact: Proper specimen counting can increase revenue by 200-400% when multiple sites are biopsied; each separately labeled container qualifies as one unit
Ensure surgical pathology requisition clearly documents each specimen's anatomic source and clinical indication before accessioning
Impact: Reduces denial risk by 35-50%; Medicare and commercial payers require specific anatomic site documentation to support multiple units
Do not bill 88305 with 88304 or 88307 for the same specimen; use the code representing the highest complexity level for that specimen
Impact: Prevents automatic denials and potential fraud flags; always code to the most complex examination performed
Use modifier 59 when billing multiple units of 88305 on same date to indicate distinct specimens from different anatomic sites
Impact: Prevents NCCI bundling edits that could deny 50-100% of additional specimen charges; essential for multiple biopsy sessions
Verify that specimen complexity truly matches 88305 criteria versus 88304 or 88307; skin tags and simple cysts are 88304, while complex resections are 88307
Impact: Coding one level too high or low affects reimbursement by $30-100 per specimen and increases audit risk significantly
For prostate biopsies, confirm payer policy on per-specimen versus per-case billing; some payers bundle all cores into one unit while Medicare allows per-container billing
Can affect revenue by $500-1000 per prostate biopsy case depending on number of cores and payer policy interpretation
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.